Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Diasome Pharmaceuticals

Clinical trials sponsored by Diasome Pharmaceuticals, explained in plain language.

A smarter insulin that aims for the liver could curb dangerous nighttime dips

Disease control Completed

This trial tests whether a specially designed mealtime insulin, HDV-insulin lispro, can reduce nighttime low blood sugar (hypoglycemia) in adults with type 1 diabetes. Participants will use continuous glucose monitors and work with doctors to adjust doses. One group receives the …

Phase 2 • Sponsor: Diasome Pharmaceuticals • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC